You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Procter & Gamble Health Q1 FY22 PAT slips 7% to Rs 55 cr

Capital Market 

On a standalone basis, Procter & Gamble (P&G) Health company's net profit fell 6.6% to Rs 55.37 crore on a 3.3% rise in net sales to Rs 272.80 crore in Q1 September 2021 over Q1 September 2020.

Milind Thatte, the managing director (MD) of Procter & Gamble Health, has said, "We delivered a strong performance in our first quarter of fiscal 2022 focused on executing our strategies of offering superior brands, driving productivity, increasing reach, and improving awareness. With the country gradually easing restrictions further due to improved vaccination coverage, we will continue our strategy to leverage technology and deliver constructive disruption to better serve our consumers and customers who count on our brands and the benefits they provide."

"While the pandemic remains, so does our commitment to step up as a #forceforgood and a #forceforgrowth guided by our three core principles; protecting the health and safety of our employees and partners, ensuring uninterrupted supplies of our quality and affordable products, and supporting communities and relief efforts through our flagship CSR program 'SEHAT' (meaning Health)," he further added.

Shares of Procter & Gamble (P&G) Health lost 0.39% at Rs 5,380 on BSE. P&G Health is one of India's largest VMS Companies manufacturing and marketing over-the-counter vitamins, minerals, and supplements products, including Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, November 10 2021. 11:00 IST